The price band for the initial public offering (IPO) of Rubicon Research has been set at ₹461–485 per share, and the company aims to raise ₹1,377.50 crore through this offering, which will be open for ...
Drug firm Rubicon Research on Monday fixed a price band at ₹461 to ₹485 per share for its upcoming initial share sale. The Mumbai-based company is set to raise ₹1,377.5 crore through its initial ...
Rubicon Research IPO opens for subscription on tomorrow (Thursday, October 9). Ahead of the opening, Rubicon Research IPO GMP today or Rubicon IPO GMP is ₹80. Rubicon Research is a company focused on ...
The initial public offering (IPO) of pharmaceutical company Rubicon Research is now open for subscription. The 3-day subscription window for Rs 1,377.50 crore will end on October 13, 2025. According ...
Canara Robeco AMC, Rubicon Research IPO Listing: Shares of Rubicon Research and Canara Robeco Asset Management Company made a positive debut on bourses on Thursday, October 16, 2025. The shares of ...
Rubicon Research IPO listing date has been scheduled for tomorrow (Thursday, October 16). Rubicon Research IPO allotment was finalised yesterday (Tuesday, October 14). For those who have been ...
Canara Robeco AMC and Rubicon Research IPOs open for subscription (Image: Canva) Two mainboard IPOs are open for subscription today, October 9 – Canara Robeco AMC and Rubicon Research. Both offer ...
Rubicon Research is scheduled to finalize the basis of allotment of its shares on Tuesday, October 14. Bidders will get the messages, alerts or emails for debit of their funds or revocations of their ...
Rubicon Research IPO Allotment Status: Investors who have applied for the Rubicon Research IPO can check their allotment status online on the websites of BSE, NSE, or the issue registrar-MUFG Intime ...
Rubicon Research IPO allotment likely to be finalised on October 14. Rubicon Research IPO share allotment is expected to be finalised later tonight, October 14, after the issue drew a whopping 104 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results